tiprankstipranks
Advertisement
Advertisement

Beta Bionics sees FY26 revenue $131M-$136M, consensus $132.58M

Sees FY26 gross margin of 57.5% to 59.5%, previously 55.5% to 57.5%. Sees 37% to 39% of new patient starts reimbursed through the PBP channel, previously 36% to 38%.

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1